Heartflow, Inc. (HTFL) stock
HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30453% above fair value
$47.07+0.21 (+0.45%)
Close on Nov 17, 2026Market cap $4.09BP/E –Yield –
Heartflow revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Heartflow's revenue for the twelve months ending Jun 30, 2026 was $212.08M, up 42.8% year over year. For fiscal 2025 it was $176.03M, up 39.9% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $176.03M | +39.9% |
| FY2024 | Dec 31, 2024 | $125.81M | +44.3% |
| FY2023 | Dec 31, 2023 | $87.17M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $64.08M | +47.6% |
| Q1 FY2026 | Mar 31, 2026 | $52.59M | +41.3% |
| Q4 FY2025 | Dec 31, 2025 | $49.13M | +40.5% |
| Q3 FY2025 | Sep 30, 2025 | $46.28M | +40.5% |
| Q2 FY2025 | Jun 30, 2025 | $43.42M | +39.8% |
| Q1 FY2025 | Mar 31, 2025 | $37.21M | – |
| Q4 FY2024 | Dec 31, 2024 | $34.98M | – |
| Q3 FY2024 | Sep 30, 2024 | $32.93M | – |
| Q2 FY2024 | Jun 30, 2024 | $31.05M | – |
See a number that looks wrong?